New Approach For The Treatment of Asthma

治疗哮喘的新方法

基本信息

  • 批准号:
    6527676
  • 负责人:
  • 金额:
    $ 76.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-09-30 至 2006-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This proposal will develop and evaluate an innovative and potential clinical treatment for asthma. Although there are a multitude of different possible triggers, an acute asthmatic attack is always characterized by contraction of the smooth muscle in the airway wall. Despite this common end point, most of the clinical asthma research and therapies in recent years have focused on understanding the immunologic factors that often lead to asthmatic attacks. The present proposal describes research and development that focuses on a treatment of smooth muscle that will thus be effective in asthmatic attacks regardless of the initial trigger. It involves the design, construction, and application of a biomedical device that can prevent or minimize the ability of the smooth muscle in the airways to constrict. The project involves a close working partnership between the physiologic laboratories and expertise at the Johns Hopkins University and a small California biomedical engineering company, that is providing the mechanical and bioengineering skills needed for product development. The overall hypothesis governing this proposal is that, the treatment of airway smooth muscle with this innovative system will minimize obstruction caused by smooth muscle contraction, regardless of its origin. In this proposal, six specific aims will be directed toward addressing this hypothesis. Two aims are concerned with determining the optimal parameters and design criteria for maximal effectiveness, and four aims are concerned with assessing the safety and potential side effects of this treatment. The information obtained from these functional studies will be essential, not only in the ongoing engineering and development of the optimal device, but also to help set guidelines for the use of this device in future clinical trials. The studies proposed in this BRP will thus allow optimization of a biomedical device that has the potential to effectively cure all forms of human asthma.
描述(由申请人提供):本提案将开发和评估 创新和潜在的哮喘临床治疗。虽然有 多种不同的可能诱因,急性哮喘发作总是 以气道壁平滑肌收缩为特征。尽管 这个共同的终点,大多数临床哮喘研究和治疗, 近年来,人们把重点放在了解免疫因素, 导致哮喘发作。本提案介绍了研究和 发展,重点是平滑肌的治疗,因此将是 对哮喘发作有效,不管最初的诱因是什么。它涉及 生物医学装置的设计、构造和应用, 阻止或最小化气道中平滑肌的能力, 收缩。该项目涉及以下各方之间的密切工作伙伴关系: 约翰霍普金斯大学的生理实验室和专业知识, 一家小型加州生物医学工程公司, 产品开发所需的机械和生物工程技能。的 支配该建议的总体假设是, 这一创新系统的平滑肌将最大限度地减少 平滑肌收缩,无论其来源如何。在这份报告中,6 具体目标将针对解决这一假设。两个目标是 有关确定最佳参数和设计标准, 最大的有效性,四个目标与评估安全性有关 和潜在的副作用获得的信息 这些功能性研究将是必不可少的,不仅在正在进行的工程中, 和最佳设备的开发,而且还有助于为 在未来的临床试验中使用该器械。本BRP中建议的研究 因此将允许优化生物医学装置, 有效治疗各种形式的人类哮喘。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wayne Mitzner其他文献

Wayne Mitzner的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wayne Mitzner', 18)}}的其他基金

Mechanism of pathogenic macrophage activation in emphysema
肺气肿致病性巨噬细胞激活机制
  • 批准号:
    10084710
  • 财政年份:
    2018
  • 资助金额:
    $ 76.31万
  • 项目类别:
Targeting AP-1 proteins in COPD
靶向 COPD 中的 AP-1 蛋白
  • 批准号:
    7837602
  • 财政年份:
    2009
  • 资助金额:
    $ 76.31万
  • 项目类别:
CORE--ENVIRONMENTAL LUNG DISEASE
核心--环境性肺病
  • 批准号:
    7393267
  • 财政年份:
    2007
  • 资助金额:
    $ 76.31万
  • 项目类别:
Responses of Contracted Airways and Parenchyma to Stretch in Vivo
体内收缩气道和实质对拉伸的反应
  • 批准号:
    7392278
  • 财政年份:
    2007
  • 资助金额:
    $ 76.31万
  • 项目类别:
Responses of Contracted Airways and Parenchyma to Stretch in Vivo
体内收缩气道和实质对拉伸的反应
  • 批准号:
    7312427
  • 财政年份:
    2006
  • 资助金额:
    $ 76.31万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    6967842
  • 财政年份:
    2004
  • 资助金额:
    $ 76.31万
  • 项目类别:
Responses of Contracted Airways and Parenchyma to Stretch in Vivo
体内收缩气道和实质对拉伸的反应
  • 批准号:
    6967823
  • 财政年份:
    2004
  • 资助金额:
    $ 76.31万
  • 项目类别:
A NEW APPROACH FOR THE TREATMENT OF ASTHMA
治疗哮喘的新方法
  • 批准号:
    7477759
  • 财政年份:
    2001
  • 资助金额:
    $ 76.31万
  • 项目类别:
A NEW APPROACH FOR THE TREATMENT OF ASTHMA
治疗哮喘的新方法
  • 批准号:
    7644888
  • 财政年份:
    2001
  • 资助金额:
    $ 76.31万
  • 项目类别:
CORE--ENVIRONMENTAL LUNG DISEASE
核心--环境性肺病
  • 批准号:
    6446924
  • 财政年份:
    2001
  • 资助金额:
    $ 76.31万
  • 项目类别:

相似海外基金

Defining new asthma phenotypes using high-dimensional data
使用高维数据定义新的哮喘表型
  • 批准号:
    2901112
  • 财政年份:
    2024
  • 资助金额:
    $ 76.31万
  • 项目类别:
    Studentship
Basophilic oncostatin M fuels nociceptor neuron-induced asthma
嗜碱性制瘤素 M 促进伤害感受器神经元诱发哮喘
  • 批准号:
    485504
  • 财政年份:
    2023
  • 资助金额:
    $ 76.31万
  • 项目类别:
    Salary Programs
Engaging Patient and Caregivers in Using Patient-reported Outcomes Measures in Pediatric Clinical Care for Asthma
让患者和护理人员参与儿科哮喘儿科临床护理中患者报告的结果测量
  • 批准号:
    495593
  • 财政年份:
    2023
  • 资助金额:
    $ 76.31万
  • 项目类别:
Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
  • 批准号:
    485322
  • 财政年份:
    2023
  • 资助金额:
    $ 76.31万
  • 项目类别:
    Operating Grants
Data-driven model links BMIz to gene expression in pediatric asthma
数据驱动模型将 BMIz 与小儿哮喘基因表达联系起来
  • 批准号:
    493135
  • 财政年份:
    2023
  • 资助金额:
    $ 76.31万
  • 项目类别:
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
  • 批准号:
    493526
  • 财政年份:
    2023
  • 资助金额:
    $ 76.31万
  • 项目类别:
    Operating Grants
A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
  • 批准号:
    10659658
  • 财政年份:
    2023
  • 资助金额:
    $ 76.31万
  • 项目类别:
Treating Maternal Depression in an Urban Community-Based Pediatric Asthma Clinic: Targeting Maternal Mood, Child Asthma Outcomes, and Health Disparities
在城市社区小儿哮喘诊所治疗孕产妇抑郁症:针对孕产妇情绪、儿童哮喘结果和健康差异
  • 批准号:
    10723233
  • 财政年份:
    2023
  • 资助金额:
    $ 76.31万
  • 项目类别:
Improving Prediction of Asthma-related Outcomes with Genetic Ancestry-informed Lung Function Equations
利用遗传祖先信息的肺功能方程改善哮喘相关结果的预测
  • 批准号:
    10723861
  • 财政年份:
    2023
  • 资助金额:
    $ 76.31万
  • 项目类别:
Prenatal Fatty Acid Supplementation and Early Childhood Asthma and Atopy in Black American Families
美国黑人家庭产前脂肪酸补充剂与儿童早期哮喘和特应性
  • 批准号:
    10586398
  • 财政年份:
    2023
  • 资助金额:
    $ 76.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了